ATARA BIOTHERAPEUTICS INC has a total of 33 patent applications. It increased the IP activity by 40.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IDM PHARMA INC, MED IMMUNE INC and STRESSGEN BIOTECHNOLOGIES CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | United States | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Computer technology | |
#6 | IT methods for management |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Data processing systems | |
#8 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Khanna Rajiv | 16 |
#2 | Aftab Blake Tolu | 11 |
#3 | Smith Corey | 8 |
#4 | Aftab Blake | 7 |
#5 | Thomas George Robin Ambalathingal | 7 |
#6 | Baiocchi Robert | 4 |
#7 | Rajiv Khanna | 4 |
#8 | Blake Tolu Aftab | 4 |
#9 | Pham Christina | 3 |
#10 | Shen Rhine | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020227595A1 | Clec4-targeted car-t-cells | |
WO2020223327A1 | Antigen specific cd19-targeted car-t cells | |
WO2020055862A1 | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto | |
EP3737394A1 | Systems and methods for distributing cell therapies | |
CA3074516A1 | Methods of managing tumor flare in adoptive immunotherapy | |
US2019350981A1 | Methods of treating multiple sclerosis using autologous t cells | |
SG11201901166QA | Immunotherapy for polyomaviruses |